ACSL1 and central nervous system cancer: A total of six genes including ACSL1 (the other five were TGFBR2, RUNX1, PPARG, GIT2, and RAP1B) have been characterized in glioma, which can interact with each other in both a competitive endogenous RNA-related manner and were predicted as markers of the mesenchymal subtype in terms of their protein functions (Wang et al., 2018).